TrialAmerican journal of clinical dermatology2025

Long-Term Disease Control and Minimal Disease Activity of Head and Neck Atopic Dermatitis in Patients Treated with Tralokinumab up to 4 Years.

Raj Chovatiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.